| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,131 |
1,078 |
$81K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
572 |
530 |
$58K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
255 |
254 |
$27K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,121 |
1,114 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31 |
31 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
43 |
41 |
$3K |
| 99177 |
|
256 |
253 |
$1K |
| 90686 |
|
276 |
275 |
$904.62 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
571 |
564 |
$685.35 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
52 |
51 |
$307.80 |
| 90473 |
|
24 |
24 |
$262.78 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
351 |
306 |
$175.81 |
| 90685 |
|
76 |
76 |
$145.06 |
| 90698 |
|
216 |
215 |
$132.72 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
29 |
28 |
$102.40 |
| 90672 |
|
25 |
25 |
$60.92 |
| 90670 |
|
263 |
262 |
$0.00 |
| 99051 |
|
29 |
28 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17 |
17 |
$0.00 |
| 90680 |
|
134 |
134 |
$0.00 |
| 90474 |
|
95 |
95 |
$0.00 |
| 90744 |
|
12 |
12 |
$0.00 |
| 36416 |
|
13 |
13 |
$0.00 |
| 96161 |
|
13 |
12 |
$0.00 |